Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Karlsson Linda, Vogel Jacob, Arvidsson Ida, Åström Kalle, Strandberg Olof, Seidlitz Jakob, Bethlehem Richard A I, Stomrud Erik, Ossenkoppele Rik, Ashton Nicholas J, Zetterberg Henrik, Blennow Kaj, Palmqvist Sebastian, Smith Ruben, Janelidze Shorena, La Joie Renaud, Rabinovici Gil D, Binette Alexa Pichet, Mattsson-Carlgren Niklas, Hansson Oskar
Аннотация
INTRODUCTION: Tau positron emission tomography (PET) is a reliable neuroimaging technique for assessing regional load of tau pathology in the brain, but its routine clinical use is limited by cost and accessibility barriers.
METHODS: We thoroughly investigated the ability of various machine learning models to predict clinically useful tau-PET composites (load and laterality index) from low-cost and non-invasive features, for example, clinical variables, plasma biomarkers, and structural magnetic resonance imaging (MRI).
RESULTS: Models including plasma biomarkers yielded the most accurate predictions of tau-PET burden (best model: R-squared = 0.66-0.69), with especially high contribution from plasma phosphorylated tau-217 (p-tau217). MRI variables were the best predictors of asymmetric tau load between the two hemispheres (best model: R-squared = 0.28-0.42). The models showed high generalizability to external test cohorts with data collected at multiple sites. Through a proof-of-concept two-step classification workflow, we also demonstrated possible model translations to a clinical setting.
DISCUSSION: This study highlights the promising and limiting aspects of using machine learning to predict tau-PET from scalable cost-effective variables, with findings relevant for clinical settings and future research.
HIGHLIGHTS: Accessible variables showed potential in estimating tau tangle load and distribution. Plasma phosphorylated tau-217 (p-tau217) and magnetic resonance imaging (MRI) were the best predictors of different tau-PET (positron emission tomography) composites. Machine learning models demonstrated high generalizability across AD cohorts.
METHODS: We thoroughly investigated the ability of various machine learning models to predict clinically useful tau-PET composites (load and laterality index) from low-cost and non-invasive features, for example, clinical variables, plasma biomarkers, and structural magnetic resonance imaging (MRI).
RESULTS: Models including plasma biomarkers yielded the most accurate predictions of tau-PET burden (best model: R-squared = 0.66-0.69), with especially high contribution from plasma phosphorylated tau-217 (p-tau217). MRI variables were the best predictors of asymmetric tau load between the two hemispheres (best model: R-squared = 0.28-0.42). The models showed high generalizability to external test cohorts with data collected at multiple sites. Through a proof-of-concept two-step classification workflow, we also demonstrated possible model translations to a clinical setting.
DISCUSSION: This study highlights the promising and limiting aspects of using machine learning to predict tau-PET from scalable cost-effective variables, with findings relevant for clinical settings and future research.
HIGHLIGHTS: Accessible variables showed potential in estimating tau tangle load and distribution. Plasma phosphorylated tau-217 (p-tau217) and magnetic resonance imaging (MRI) were the best predictors of different tau-PET (positron emission tomography) composites. Machine learning models demonstrated high generalizability across AD cohorts.